So This Weeks Talk is Called: Sexs, Drugs, and Resistance or why I came to Peru. About four years ago now, I was a first year medical student, generally impressed with the inside of the (dead) human body and its nearly non-sensical ability to construct a defense mechanism capable of recognizing (for decades on end) literally billions of foriegn entities. But generally unimpressed with Baltimore, with it's unflapable history of abject poverty and congenital racism. I missed California (where, lest I forget, I really truly always wanted to be). I met an older medical student who spent his first summer of medical school (the first and only break usually spent traveling, researching, or relaxing) working for an STD guru out in San Francisco. I thought I liked infectious disease and was sure I loved San Francisco. A phone and lunch time interview later, I had my most influential mentor of my young career. Jeffrey Klausner has the perfect job. By day he directs the world's best public STD clinic, formulates health policy to prevent disease transmission, works at an HIV clinic, and rounds at the SF general hospital. By night and weekend he hops from Peru to Africa to Thailand consulting and directing international studies. In between he has a wife and three kids, with soccer practice, school plays, and a two week per summer beach house in Mairn County. Hopefully he'll move on in about 6 years when I'm done with my training.
My first job for Jeff was to conduct a small study to analyze rapid tests for syphilis, an STD which usually requires a blood draw to diagnose. I spent a summer comparing these rapid tests (a finger stick much like a test for diabetes) to standard tests, and published an article showing they work very well (and acting as phil the syphilis sore in the SF gay pride parade).
My first job for Jeff was to conduct a small study to analyze rapid tests for syphilis, an STD which usually requires a blood draw to diagnose. I spent a summer comparing these rapid tests (a finger stick much like a test for diabetes) to standard tests, and published an article showing they work very well (and acting as phil the syphilis sore in the SF gay pride parade).

About a year and a half later, I called Jeff asking him if he had any projects for me abroad. He sent me to Peru for a month, where, with a laboratory doctor, I worked to develop a new test for gonorrhea. Gonorrhea has been resistant to Penicillin for years, it has mutated a Penicilllin binding protein that Penicillin must bind to in order to exact its effect. So the choices to treat Penicillin in many places have decreased, to a newer Penicillin-like antibiotic (called a cephalosporin) which often requires an injection, or a new class of drugs, called Fluoroquinolones. Unfortunately, gonorrhea has recently become resistnat to fluoroquinolones in much of the world too, again through mutation of a protein that the antibiotic binds too. Mark Pandori (the laboratorian) and I developed a new test that looks specifically at the DNA (using PCR) to see if the bacteria has the normal (or sensitive protein) or the mutant (resistant protein). I came to Peru to test the new assay and see if we could find any Quinolone resistant Neisseria gonorrhea (QRNG). And we did! About 16% of the samples we tested were QRNG. That is important in Peru, because, unlike in the United States, were people are often treated after a specific gonorrhea test, in Peru people are treated clinically, which means that if a patient has discharge from the penis or cervis, a doctor gives them an antibiotic without a test. In Peru, because they are cheap and do not require injection, quinolones are usually used. This could be a major problem if 16% of the bacteria are resistant! We need to test many more samples to be sure, but for now, we have made an interesting finding.
In the meantime, I am doing some other similar work. Most notably we have also developed a new test that does a similar thing for Syphilis (looks to see if the syphilis is resistant to antibiotics) and a test looking for specific kinds of chlamydia that can cause specific symptoms and problems in gay men (or as they are called in scientific literature - MSM - men who have sex with men, to include those who may not consider themselves gay or who also have sex with women). All and all, it has been an interesting line of work. Ultimately, in Peru and SF, STD work is mostly working with MSM. Other sub-populations are much less affected. The social and political charactersitics of this work are facsinating and certainly add to the intrigue of the field. However, ultimately, as a straight male in the field, I do not think it is my fight. This year, working with TB, may have helped me shift my gears to diseases with less political complexity and more widesweeping impact on the poor, irrespective of sexual orientation.
In the meantime, I am doing some other similar work. Most notably we have also developed a new test that does a similar thing for Syphilis (looks to see if the syphilis is resistant to antibiotics) and a test looking for specific kinds of chlamydia that can cause specific symptoms and problems in gay men (or as they are called in scientific literature - MSM - men who have sex with men, to include those who may not consider themselves gay or who also have sex with women). All and all, it has been an interesting line of work. Ultimately, in Peru and SF, STD work is mostly working with MSM. Other sub-populations are much less affected. The social and political charactersitics of this work are facsinating and certainly add to the intrigue of the field. However, ultimately, as a straight male in the field, I do not think it is my fight. This year, working with TB, may have helped me shift my gears to diseases with less political complexity and more widesweeping impact on the poor, irrespective of sexual orientation.


